Lineage Cell Therapeutics (LCTX) Gross Profit (2011 - 2025)
Lineage Cell Therapeutics' Gross Profit came in at $1.47 million for Q1 2025, up 8.9% from $1.35 million a year earlier but down 46.0% from the prior quarter.
Powered by 
Analysis
Lineage Cell Therapeutics (LCTX) Gross Profit (2011 - 2025) Analysis & Trends
Over the trailing twelve months to Mar 31, 2025, Lineage Cell Therapeutics reported Gross Profit of $9.29 million, up 26.3% year-over-year; for FY2024, it was $9.17 million, up 10.8% from FY2023.
- Gross Profit carries a five-year compound annual growth rate of 24.2% (FY2019 to FY2024).
- Going back by year, Gross Profit was $8.27 million in FY2023 (-40.8%), $13.98 million in FY2022 (+379.4%), $2.92 million in FY2021 (+102.3%) and $1.44 million in FY2020 (-53.6%).
- The five-year range for quarterly Gross Profit is $241,000 (Q4 2020) to $5.06 million (Q1 2022).
- Year-over-year, Gross Profit has increased for three consecutive quarters, with growth averaging 14.9% over the last eight quarters.
- The fastest year-over-year change in Gross Profit over five years came in Q4 2021 (growth of 300.0%), and the weakest in Q4 2020 (a decline of 78.4%).
- Business Quant data shows LCTX's Gross Profit at $2.71 million (Q4 2024), $3.74 million (Q3 2024) and $1.36 million (Q2 2024) in the three quarters before Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Lineage Cell Therapeutics | 240.26 Mn | 38.67 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | 1.47 Mn |
| Dec 31, 2024 | 2.71 Mn |
| Sep 30, 2024 | 3.74 Mn |
| Jun 30, 2024 | 1.36 Mn |
| Mar 31, 2024 | 1.35 Mn |
| Dec 31, 2023 | 1.83 Mn |
| Sep 30, 2023 | 1.08 Mn |
| Jun 30, 2023 | 3.10 Mn |
| Mar 31, 2023 | 2.27 Mn |
| Dec 31, 2022 | 1.81 Mn |
| Sep 30, 2022 | 2.76 Mn |
| Jun 30, 2022 | 4.34 Mn |
| Mar 31, 2022 | 5.06 Mn |
| Dec 31, 2021 | 964,000.00 |
| Sep 30, 2021 | 1.29 Mn |
| Jun 30, 2021 | 387,000.00 |
| Mar 31, 2021 | 279,000.00 |
| Dec 31, 2020 | 241,000.00 |
| Sep 30, 2020 | 469,000.00 |
| Jun 30, 2020 | 311,000.00 |
API Access
Lineage Cell Therapeutics Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=LCTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "LCTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=LCTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();